Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 374163103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13G/A
|
9.9% |
8/14/2026
Event 6/30/2026
|
||
| RA Capital Management, L.P. | 9.9% | |||
| Peter Kolchinsky | 9.9% | |||
| Rajeev Shah | 9.9% | |||
| RA Capital Healthcare Fund, L.P. | 9.9% | |||
|
Soleus Capital Master Fund, L.P.
13G/A
|
6.5% |
5/8/2026
Event 3/31/2026
|
||
| Soleus Capital Master Fund, L.P. | 6.5% | |||
| Soleus Capital, LLC | 6.5% | |||
| Soleus Capital Group, LLC | 6.5% | |||
| Soleus Capital Management, L.P. | 6.5% | |||
| Soleus GP, LLC | 6.5% | |||
| Guy Levy | 6.5% | |||
| State Street Corp 13G | 5.6% |
8/7/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Deep Track Capital, LP
13G/A
|
4.95% |
5/15/2026
Event 3/31/2026
|
||
| Deep Track Capital, LP | 4.95% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 4.95% | |||
| David Kroin | 4.95% | |||
|
RTW Investments, LP
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| RTW Investments, LP | 0% | |||
| Roderick Wong, M.D. | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 302 k | $372 k |
| 2026 Q2 | 272 | 490 M | $1.17 B |
| 2026 Q1 | 267 | 497 M | $741 M |
| 2025 Q4 | 275 | 479 M | $632 M |
| 2025 Q3 | 277 | 509 M | $697 M |
| 2025 Q2 | 271 | 515 M | $726 M |
| 2025 Q1 | 284 | 510 M | $812 M |
| 2024 Q4 | 300 | 489 M | $1.73 B |
| 2024 Q3 | 270 | 510 M | $2.32 B |
| 2024 Q2 | 254 | 467 M | $1.98 B |
| 2024 Q1 | 247 | 443 M | $1.46 B |
| 2023 Q4 | 218 | 409 M | $863 M |
| 2023 Q3 | 213 | 371 M | $787 M |
| 2023 Q2 | 212 | 344 M | $1.10 B |
| 2023 Q1 | 201 | 326 M | $706 M |
| 2022 Q4 | 212 | 230 M | $560 M |
| 2022 Q3 | 202 | 190 M | $448 M |
| 2022 Q2 | 165 | 194 M | $305 M |
| 2022 Q1 | 161 | 183 M | $258 M |
| 2021 Q4 | 161 | 130 M | $164 M |
| 2021 Q3 | 148 | 132 M | $187 M |
| 2021 Q2 | 157 | 130 M | $189 M |
| 2021 Q1 | 158 | 144 M | $233 M |
| 2020 Q4 | 169 | 176 M | $286 M |
| 2020 Q3 | 168 | 172 M | $305 M |
| 2020 Q2 | 157 | 156 M | $344 M |
| 2020 Q1 | 131 | 61.3 M | $72.9 M |
| 2019 Q4 | 130 | 65.5 M | $89.0 M |
| 2019 Q3 | 130 | 59.4 M | $79.0 M |
| 2019 Q2 | 134 | 59.6 M | $84.1 M |
| 2019 Q1 | 137 | 58.7 M | $97.5 M |
| 2018 Q4 | 159 | 64.4 M | $64.4 M |
| 2018 Q3 | 183 | 58.6 M | $103 M |
| 2018 Q2 | 162 | 71.2 M | $239 M |
| 2018 Q1 | 148 | 60.5 M | $257 M |
| 2017 Q4 | 125 | 59.3 M | $107 M |
| 2017 Q3 | 121 | 62.4 M | $136 M |
| 2017 Q2 | 123 | 61.8 M | $171 M |
| 2017 Q1 | 119 | 60.9 M | $138 M |
| 2016 Q4 | 123 | 61.3 M | $127 M |
| 2016 Q3 | 132 | 59.9 M | $135 M |
| 2016 Q2 | 135 | 60.7 M | $170 M |
| 2016 Q1 | 134 | 67.4 M | $197 M |
| 2015 Q4 | 148 | 68.8 M | $336 M |
| 2015 Q3 | 135 | 71.3 M | $197 M |
| 2015 Q2 | 143 | 72.1 M | $308 M |
| 2015 Q1 | 129 | 68.4 M | $258 M |
| 2014 Q4 | 130 | 65.9 M | $214 M |
| 2014 Q3 | 133 | 71.1 M | $142 M |
| 2014 Q2 | 140 | 76.0 M | $247 M |
| 2014 Q1 | 149 | 82.8 M | $173 M |